Efficacy of Oral Cancer Screening Adjunctive Techniques
Efficacy of Oral Cancer Screening Adjunctive Techniques
批准号:
7854096
负责人:
MARK W. LINGEN
金额:
$77.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-28 至 2012-08-31
关键词:
AddressAdvisory CommitteesAffectAreaCancer DetectionChicagoClinical ResearchClinical Trials DesignClinical and Translational Science AwardsCommunicationCommunitiesCommunity NetworksComputer SystemsConsentDataData CollectionDentalDental General PracticeDetectionDevicesDiagnosisDiseaseEarly DiagnosisEnrollmentEnsureEvaluationFloridaGeneral PopulationGoalsGuidelinesImageInstitutionLesionMalignant - descriptorMalignant NeoplasmsManualsMedicalMinorityMonitorNational Institute of Dental and Craniofacial ResearchNew YorkOralOral ExaminationOral mucous membrane structureOropharyngealOutcomeParticipantPatientsPopulationPopulation HeterogeneityPremalignantPreventivePrimary Health CareProceduresProgress ReportsProviderPublic HealthRandomizedRandomized Controlled Clinical TrialsRandomized Controlled TrialsRecommendationRecoveryResearchResearch DesignResearch InfrastructureRiskSafetySample SizeScreening for Oral CancerScreening procedureSecondary PreventionServicesSiteStandardizationStudy SubjectTactileTechniquesTexasThird-Party PayerTimeTissue BankingTissue BanksTrainingTreatment ProtocolsUnited StatesUniversitiesVisualWashingtonWorkWritingbasecost effectivenessdata managementdata sharingdesigndiagnostic accuracyfollow-uphigh riskimprovedmalignant mouth neoplasmpharynx squamous cell carcinomapractice-based research networkpublic health relevancetreatment planningtrial comparing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application addresses Recovery Act Limited Competition: Research and Research Infrastructure "Grand Opportunities" (GO) (RC2): NIDCR guidelines, RFA-OD-09-004: Area of Scientific Priority 4) Detection of Oral Premalignant and Malignant Lesions. This proposal will compare the diagnostic accuracy of three screening regiments for oral pre-malignant and malignant lesions: conventional oral and tactile examination and conventional exam plus one of two adjunctive devices. This study will be particularly informative because it will be conducted both in communities disproportionately affected by oral cancer, and in patients, similar to those found in private dental practices, who are likely at lower risk of developing pre-malignant or malignant lesions. We also believe that our multi-center approach involving Practice based research networks (PBRN) (to ensure participation of practicing clinicians) and Clinical and Translational Science Awards (CTSA) (to work within an established network of community, academic and public health partners) will help to successfully address many of the challenges that arise in community-based research. Specific Aims: Specific Aim #1: Design a multi-center randomized controlled clinical trial to estimate and compare the diagnostic accuracy of three screening regimens: a) visual and tactile oral examination, b) visual and tactile oral examination + Velscope, and c) visual and tactile oral examination + Trimara OCS 3000. Specific Aim #2: Develop a tactical plan for the safe, rapid and rigorous execution and analysis of the proposed trial. Specific Aim #3: Write a detailed Manual of Procedures (MOP) for conducting the proposed trial.
PUBLIC HEALTH RELEVANCE: It has been postulated that the addition of commercially available adjunctive screening devices to the conventional visual and tactile exam will aid in the identification of premalignant or early malignant lesions. However, the incremental benefit in terms of increasing diagnostic accuracy as well as the cost effectiveness of these devices has not been adequately evaluated. Furthermore, it is unknown if these devices will be most useful when they are applied to general and/or high risk populations. In addition, their utility may vary among different ethnic populations. A rigorous evaluation of these devices would inform dental and medical professionals, third-party payers, and the public regarding their value and appropriate use. Our goal is to develop a comprehensive plan to conduct a large multi-center trial that will primarily compare visual and tactile oral mucosal examination with screening device-assisted examination as performed by primary care providers in diverse populations, including minorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Profiling of Premalignant Oral Lesions
-
批准号:6965411
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Molecular Profiling of Premalignant Oral Lesions
-
批准号:7235630
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Molecular Profiling of Premalignant Oral Lesions
-
批准号:7095254
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Oral Cancer, Chemoprevention, and Anti-Angiogenesis
-
批准号:6925915
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Oral Cancer, Chemoprevention, and Anti-Angiogenesis
-
批准号:7103714
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Oral Cancer, Chemoprevention, and Anti-Angiogenesis
-
批准号:7227524
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Oral Cancer, Chemoprevention, and Anti-Angiogenesis
-
批准号:7616443
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Oral Cancer, Chemoprevention, and Anti-Angiogenesis
-
批准号:7424992
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
Molecular Profiling of Premalignant Oral Lesions
-
批准号:7470024
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2005
-
负责人:MARK W. LINGEN
-
依托单位:
AUTO TISSUE ARRAYER: CROHN'S DISEASE, CELIAC DISEASE, INFLAMMATORY BOWEL DISEASE
-
批准号:6973394
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2004
-
负责人:MARK W. LINGEN
-
依托单位:
Automated Tissue Arrayer
-
批准号:6732473
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2004
-
负责人:MARK W. LINGEN
-
依托单位:
AUTO TISSUE ARRAYER: ASTHMA
-
批准号:6973395
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2004
-
负责人:MARK W. LINGEN
-
依托单位:
AUTO TISSUE ARRAYER: CANCER: PROSTATE, ORAL, LUNG, LEUKEMIA, COLON, BREAST
-
批准号:6973393
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2004
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6758884
-
项目类别:
-
资助金额:$8.93万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6516356
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6651165
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6230518
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6896776
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER
-
批准号:6775721
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2001
-
负责人:MARK W. LINGEN
-
依托单位:
ORAL CANCER, RETINOIDS, AND ANTIANGIOGENESIS
-
批准号:2897163
-
项目类别:
-
资助金额:$16.51万
-
财政年份:1998
-
负责人:MARK W. LINGEN
-
依托单位:
海外基金